EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Identification and Validation of Serum Biomarkers to Improve Colorectal Cancer Diagnosis

Minha Lea Yoon, Hyelim Chun, HyunJu Lee, WooJeong Seo, Jung Young Lee, Jung Hwan Yoon iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70460 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Minha Lea Yoon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Center, Gangnam St. Peter's Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, ROC Curve. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health and Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The pressing need for reliable biomarkers in colorectal cancer (CRC) diagnosis and prognosis is a major global health concern. Current diagnostic methods rely heavily on invasive procedures like colonoscopy, and existing biomarkers such as Carbohydrate Antigen 19‐9 (CA19‐9) and Carcinoembryonic Antigen (CEA) exhibit limitations in accuracy and specificity.

Aims

This study aims to identify and validate novel biomarkers that can enhance the early detection and diagnostic precision of CRC while overcoming the shortcomings of conventional biomarkers. Materials and Methods Leveraging advancements in genomic and proteomic technologies, gene expression datasets were obtained from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA). We identified differentially expressed genes (DEGs) and conducted further analyses, including Gene Ontology (GO) enrichment and Protein‐Protein Interaction (PPI) network construction. Five promising biomarkers—INHBA, MMP7, PSAT1, SLC7A5, and TGFBI—were selected based on their robust performance in Receiver Operating Characteristic (ROC) curve analysis. Serum concentrations of these biomarkers were measured in 200 CRC patients and 100 healthy controls.

Results

The study revealed significantly elevated expression levels of the selected biomarkers in CRC tissues compared to normal tissues. Additionally, serum concentrations of INHBA, MMP7, PSAT1, SLC7A5, and TGFBI were notably higher in CRC patients than in healthy individuals, with Area Under the Curve (AUC) values ranging from 0.8361 to 0.9869 indicating high diagnostic accuracy. Optimal cutoff values for diagnosis ranged from 38.9 pg/mL to 280.7 pg/mL, yielding sensitivity and specificity values between 74.5% and 92.9%.

Discussion

The findings underscore the potential of INHBA, MMP7, PSAT1, SLC7A5, and TGFBI as effective non‐invasive biomarkers for CRC detection. Their elevated serum concentrations and robust discriminatory abilities highlight their promise in improving diagnostic accuracy and patient outcomes compared to traditional biomarkers.

Conclusion

The identification and validation of these novel biomarkers represent a significant advancement in CRC diagnosis and management. Further studies are required to validate their clinical applicability in larger cohorts and to elucidate their functional roles in CRC pathogenesis, ultimately enhancing diagnostic strategies and personalized treatment approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsBiomarkers, TumorROC CurveHumansMaleFemaleMiddle AgedMatrix Metalloproteinase 7Protein Interaction MapsInhibin-beta SubunitsAgedGene Expression Regulation, NeoplasticCase-Control StudiesEarly Detection of CancerPrognosis

Stichwörter der Autor:innen

ELISAbiomarkerscolorectal cancerdiagnosis

Substanzen

Biomarkers, TumorMatrix Metalloproteinase 7Inhibin-beta Subunitsinhibin beta A subunitMMP7 protein, human

Autor:innen und Institutionen

  • Clinical Trial Center, Gangnam St. Peter's Hospital, Seoul, Republic of Korea.
  • Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

ORCID-Profile: Jung Hwan Yoon

Förderung

  • Ministry of Health and Welfare, Republic of Korea

Zitieren

APA

Yoon, M. L., Chun, H., Lee, H., Seo, W., Lee, J. Y., & Yoon, J. H. (2024). Identification and Validation of Serum Biomarkers to Improve Colorectal Cancer Diagnosis. Cancer Medicine. https://doi.org/10.1002/cam4.70460

Vancouver

Yoon ML, Chun H, Lee H, Seo W, Lee JY, Yoon JH. Identification and Validation of Serum Biomarkers to Improve Colorectal Cancer Diagnosis. Cancer Medicine. 2024. doi:10.1002/cam4.70460

BibTeX
@article{Yoon2024,
  author = {Yoon, Minha Lea and Chun, Hyelim and Lee, HyunJu and Seo, WooJeong and Lee, Jung Young and Yoon, Jung Hwan},
  title = {Identification and Validation of Serum Biomarkers to Improve Colorectal Cancer Diagnosis},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70460}
}
Kostenlos starten →